Mitch determines the fate of fat in human cells
Tucked within nearly every human cell, a single protein called MTCH2 has long been quietly deciding whether fat is burned or preserved — a molecular gatekeeper whose influence, researchers at the Weizmann Institute of Science are now revealing, extends from the architecture of our mitochondria to the very formation of fat cells themselves. By disabling this protein in human cells, scientists observed a cascade of metabolic shifts: cells burned harder, favored fat as fuel, and lost their capacity to generate new fat-storing tissue. The discovery, still in its early cellular stages, points toward a potential obesity treatment that might spare muscle while targeting excess fat — a balance that has long eluded medicine.
- A protein nicknamed 'Mitch' has been found to act as a master switch controlling whether human cells burn fat or store it — a finding that reframes how scientists understand metabolic regulation.
- When MTCH2 is disabled, mitochondria fragment into inefficient units, forcing cells into a perpetual energy deficit that drives them to consume more fat, carbohydrates, and proteins just to function.
- Beyond burning existing fat, the absence of MTCH2 also prevents precursor cells from maturing into fat-storing cells, blocking the very conditions needed for fat synthesis and differentiation.
- The dual mechanism — burning fat while halting new fat cell formation — addresses one of obesity treatment's most stubborn challenges: losing fat without sacrificing muscle.
- The research, published in the EMBO Journal and involving collaborators from two American universities, remains at the cellular stage, but its implications are already rippling through the scientific community.
A protein found in nearly every human cell may hold a key to treating obesity. Researchers at the Weizmann Institute of Science have spent years studying MTCH2 — called 'Mitch' in the lab — and their findings suggest it functions as a metabolic gatekeeper, determining whether fat is burned or stored.
The investigation began with mice. Prof. Atan Gross and his team noticed that animals engineered to lack the protein didn't just resist weight gain — they became leaner and more athletic, developing endurance-associated muscle fibers and outperforming normal mice under physical stress. The question was whether the same mechanism operated in human cells.
The answer centered on mitochondria. Mitch, the team discovered, controls whether mitochondria fuse into large efficient networks or fragment into smaller, less productive units. Fragmentation forces cells into a state of chronic energy shortage, compelling them to burn more fuel. Doctoral student Sabita Chourasia confirmed this in human cells: removing Mitch caused mitochondrial networks to collapse, cellular respiration to intensify, and — crucially — cells to shift away from carbohydrates and toward fat as their primary energy source. Fats were even stripped from cell membranes to meet the demand.
The protein's reach extended further still. When removed from fat cell precursors, Mitch's absence made the environment hostile to fat synthesis — suppressing the genes, energy, and molecular conditions needed for new fat cells to form. The result was a dual effect: existing fat burned faster, and new fat cells simply failed to develop.
For obesity research, this matters because most treatments reduce fat at the cost of muscle. A therapy targeting MTCH2 might sidestep that trade-off entirely. The work remains in early cellular stages, but with collaborators from the University of Pennsylvania and the University of Texas at San Antonio already involved, the findings are beginning to travel.
A protein tucked inside nearly every cell in the human body may offer a new path toward treating obesity. Researchers at the Weizmann Institute of Science have spent years studying a molecule called MTCH2—nicknamed "Mitch" in the lab—and what they've found suggests it acts as a kind of metabolic gatekeeper, deciding whether fat gets burned or stored. When they disabled the protein in human cells, something striking happened: the cells burned more fat, consumed more energy overall, and became far less capable of developing into fat-storing cells.
The story began with mice. Several years ago, Prof. Atan Gross and his team were investigating Mitch's role in muscle tissue when they noticed something unexpected. Mice engineered to lack the protein didn't just avoid gaining weight—they became leaner and more athletic. Their muscles developed more of the oxygen-hungry fibers associated with endurance and stamina. During physical stress tests, these animals outperformed normal mice. Their hearts functioned better. The observation raised an obvious question: how could removing a single protein simultaneously protect against obesity and enhance physical fitness?
The answer lay in mitochondria, the cellular structures responsible for generating energy. Gross's team discovered that Mitch controls whether mitochondria fuse together into large, efficient networks or fragment into smaller, less efficient units. When mitochondria become fragmented, cells struggle to produce energy efficiently. They compensate by consuming more fuel—more fats, more carbohydrates, more proteins. It was a clue that might explain the mouse results, but the researchers needed to know if the same mechanism worked in human cells.
In a new study published in the EMBO Journal, doctoral student Sabita Chourasia used genetic engineering to remove Mitch from human cells. The results were dramatic. Without the protein, mitochondrial networks collapsed into separate fragments. Energy production became inefficient. Cells found themselves in what researchers call a constant state of energy shortage. Chourasia examined over 100 metabolic substances in these altered cells every few hours and found that cellular respiration—the process by which cells extract energy from nutrients using oxygen—had increased significantly. The cells were burning harder, working harder, consuming more fuel just to survive.
What fuel were they consuming? That's where the findings became particularly interesting. Normal cells typically rely more heavily on carbohydrates and proteins for energy. Cells without Mitch shifted dramatically toward fat as their primary fuel source. Gross observed that fats were being stripped from cell membranes and burned for energy. In essence, Mitch appeared to determine the fate of fat in human cells—whether it would be stored or consumed.
But the protein's influence extended beyond just burning existing fat. The researchers investigated whether Mitch might also affect the creation of new fat cells. Fat cells don't appear fully formed; they develop from precursor cells called progenitor cells, which accumulate fat and mature through a process called differentiation. When Mitch was removed from these progenitor cells, the transformation became far more difficult. Without the protein, the cellular environment became hostile to fat synthesis. Cells couldn't generate the energy needed for growth and development. Genes necessary for the differentiation process were suppressed. The substances vital for fat cell maturation became scarce. The result: new fat cells simply didn't form.
So Mitch appeared to work on two fronts simultaneously. It increased the rate at which existing fat was burned for energy while also blocking the formation of new fat-storing cells. For obesity research, this dual mechanism is significant. Most weight loss treatments struggle with a persistent problem: they reduce body fat but also strip away muscle. A therapy targeting Mitch might avoid that trade-off, preserving healthy muscle while reducing excess fat. The work remains in early stages—conducted in cells, not yet in animals or humans—but it reveals a biological pathway that could reshape how researchers approach obesity treatment. The study involved collaborators from the University of Pennsylvania and the University of Texas at San Antonio, suggesting that the findings have already begun to spread across the research community.
Notable Quotes
After deleting Mitch, we saw an increase in cellular respiration, the process in which the cell produces energy from nutrients such as carbohydrates and fats, using oxygen.— Sabita Chourasia, doctoral student leading the study
Mitch determines the fate of fat in human cells—whether it will be stored or burned.— Prof. Atan Gross, Weizmann Institute
The Hearth Conversation Another angle on the story
So this protein, Mitch—it's something every cell has?
Yes. It's present in most human cells. The question was never whether it exists, but what it actually does. For years, researchers knew it was involved in mitochondrial function, but the full picture wasn't clear.
And when you remove it, cells just... burn more fat?
Not quite. When you remove it, cells become inefficient at producing energy. They're essentially starving for power. So they consume more fuel—any fuel available—to meet their needs. Fat happens to be a very accessible fuel source.
Why would that be useful for obesity treatment? Doesn't that sound exhausting for the cell?
It is, in a sense. But that's actually the point. If you could trigger that state in fat tissue specifically, you'd have cells burning through their reserves constantly. And simultaneously, new fat cells couldn't form because they lack the energy and molecular conditions to develop.
So it's not about making cells work harder in a healthy way—it's about creating a controlled energy crisis?
That's one way to frame it. Though I'd say it's more about redirecting how cells use energy. The mice without Mitch weren't sick or weak. They were actually more athletic. So the inefficiency, in this context, appears to be beneficial.
How far away is this from an actual drug?
Still quite far. This work is in isolated human cells. You'd need to test it in animals, understand the side effects, figure out how to target Mitch specifically in fat tissue without affecting other organs. Years of work ahead. But the pathway is now visible.
And if it works, what makes it different from other obesity treatments?
Most therapies either suppress appetite or increase metabolism broadly. This one specifically addresses how fat is stored and burned at the cellular level, while apparently preserving muscle. That combination is rare.